Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Xiang-An Li, PhD

xiangan li
  • About

    Faculty Rank

    Associate Professor
  • Publications

    1. Scavenger receptor BI and HDL regulate thymocyte apoptosis in sepsis. Guo L, Zheng Z, Ai J, Deborah AH, Mittelstadt PR, Thacker S, Daugherty A, Ashwell JD, Remaley A and Li XA*. Arterioscler Thromb Vasc Biol 2014; 34: 966-975. PMC4010389
    2. Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice. Guo L, Zheng Z, Ai J, Huang B and Li XA*. J Biol Chem 2014; 289: 14666-14673. PMC4031522.
    3. Corticosteroid therapy benefits septic mice with adrenal insufficiency but harms septic mice without adrenal insufficiency. Ai J, Guo L, Zheng Z, Wang SX, Huang B and Li XA*. Critical Care Medicine 2015; 43: e490-e498.
    4. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer. Yun B, Wu C, Wang X, Wang D, Liu H, Guo L, Li XA*, Han J* and Feng H*. Tumor Biol 2015; DOI 10.1007/s13277-015-4141-4.
    5. PI(4)P promotes phosphorylation and conformational change of Smoothened through interaction with its C-terminal tail. Jiang K, Liu Y, Fan J, Zhang J, Li XA, Evers M, Zhu H and Jia J. PloS Biol 2015 (in press).
  • Research

    Cancer Center Member

    Research Focus

    Role of SR-BI in cancer:

    Cancer cells exhibit altered metabolism including high demand for cholesterol for rapid cell proliferation. Scavenger receptor BI (SR-BI) is a HDL receptor. It mediates the uptake of cholesterol from HDL. Recent studies including ours indicate that SR-BI is highly expressed in breast cancer and the levels of SR-BI expression are negatively correlated with cancer survival. We hypothesize that SR-BI-mediated cholesterol uptake from HDL provides cholesterol for cancer cell growth, and blocking SR-BI-mediated cholesterol uptake from HDL inhibits cancer cell proliferation, which may provide a novel approach for cancer therapy. We currently use a combination of molecular, cellular and genetically manipulated animal models to test our hypothesis.


    • Molecular and Cellular Oncology

    College & Department

    • College of Medicine
    • Department of Pediatrics

    For Referring Physicians

    BBSRB B255
    741 S. Limestone
    Lexington, KY 40536
    United States

  • Locations

    Insurance Information

    Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers Arrow Pointing Right

Update/Correct This Profile.